A sequential deposition of amyloid beta oligomers, plaques and phosphorylated tau occurs throughout life in the canine retina

U. Habiba, J. Morley, M. Krockenberger, B. Summers, M. Tayebi
{"title":"A sequential deposition of amyloid beta oligomers, plaques and phosphorylated tau occurs throughout life in the canine retina","authors":"U. Habiba, J. Morley, M. Krockenberger, B. Summers, M. Tayebi","doi":"10.20517/and.2022.06","DOIUrl":null,"url":null,"abstract":"Aims: Cerebral amyloid burdens may be found in otherwise cognitively intact adults, often not showing worsening deficits with passing years. Alzheimer’s transgenic rodents have been widely used to investigate this phenomenon, but a spontaneous disorder in other animals, such as dogs that cohabit with humans and thus may have some shared environmental risks, may contribute and offer opportunities not possible in the smaller laboratory animals. In animals, the spontaneous disorder most comparable to Alzheimer’s disease (AD) affects mature to aged dogs and is designated canine cognitive dysfunction. Motivated by AD, many studies have revealed that amyloid progressively accumulates in the canine central nervous system, including the retina. Here, we investigated whether deposits of amyloid and/or tau can be found in the canine retina of neurologically normal animals from the first year of life to the elderly. Suppose canine ocular amyloid and tau are present from early life. In that case, that raises the question of whether similar patterns of accumulation occur in man, whether as part of aging, AD, or other. Methods: This study used eye tissues from 30 dogs with a variety of ophthalmic or other orbital disorders, of which 7/30 were 1-2 years old. Tissues were subdivided into dogs of three different age groups: young (1-5 years old), middle (6-10 years old), and old (≥ 11 years old). Results: Following immunostaining of tissue sections with nanobodies against retinal Aβ1-40 and Aβ1-42 oligomers, and antibodies against Aβ plaques (Aβp) and hyperphosphorylated Tau (p-Tau), our investigations revealed that accumulation of Aβ1-40 and Aβ1-42 oligomers were widespread in the retina in all age groups. In contrast, Aβp were detected in the middle and old age groups but not in the young age group. Furthermore, p-Tau staining was observed in four old dogs only, while other dogs were p-Tau free. Interestingly, both Aβo and Aβp co-localized in the middle and old age groups of dogs. Moreover, diffuse granular p-Tau co-localized with intracellular Aβo in the old age group. Finally, we also observed co-localization of Aβo and Aβp in the retinal vasculature which might be similar to cerebral amyloid angiopathy associated with AD. Conclusion: As far as we know, the presence of amyloid and tau in the canine retina is hitherto unreported. If similar, early-in-life subclinical retinal deposits occur in a human cohort perhaps identified by AD genetic risk factors, following this group may offer the prospect of preclinical therapeutic intervention in imminent dementia, a strategy recognized as likely necessary to impact this burgeoning disorder.","PeriodicalId":93251,"journal":{"name":"Ageing and neurodegenerative diseases","volume":"25 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ageing and neurodegenerative diseases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.20517/and.2022.06","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Aims: Cerebral amyloid burdens may be found in otherwise cognitively intact adults, often not showing worsening deficits with passing years. Alzheimer’s transgenic rodents have been widely used to investigate this phenomenon, but a spontaneous disorder in other animals, such as dogs that cohabit with humans and thus may have some shared environmental risks, may contribute and offer opportunities not possible in the smaller laboratory animals. In animals, the spontaneous disorder most comparable to Alzheimer’s disease (AD) affects mature to aged dogs and is designated canine cognitive dysfunction. Motivated by AD, many studies have revealed that amyloid progressively accumulates in the canine central nervous system, including the retina. Here, we investigated whether deposits of amyloid and/or tau can be found in the canine retina of neurologically normal animals from the first year of life to the elderly. Suppose canine ocular amyloid and tau are present from early life. In that case, that raises the question of whether similar patterns of accumulation occur in man, whether as part of aging, AD, or other. Methods: This study used eye tissues from 30 dogs with a variety of ophthalmic or other orbital disorders, of which 7/30 were 1-2 years old. Tissues were subdivided into dogs of three different age groups: young (1-5 years old), middle (6-10 years old), and old (≥ 11 years old). Results: Following immunostaining of tissue sections with nanobodies against retinal Aβ1-40 and Aβ1-42 oligomers, and antibodies against Aβ plaques (Aβp) and hyperphosphorylated Tau (p-Tau), our investigations revealed that accumulation of Aβ1-40 and Aβ1-42 oligomers were widespread in the retina in all age groups. In contrast, Aβp were detected in the middle and old age groups but not in the young age group. Furthermore, p-Tau staining was observed in four old dogs only, while other dogs were p-Tau free. Interestingly, both Aβo and Aβp co-localized in the middle and old age groups of dogs. Moreover, diffuse granular p-Tau co-localized with intracellular Aβo in the old age group. Finally, we also observed co-localization of Aβo and Aβp in the retinal vasculature which might be similar to cerebral amyloid angiopathy associated with AD. Conclusion: As far as we know, the presence of amyloid and tau in the canine retina is hitherto unreported. If similar, early-in-life subclinical retinal deposits occur in a human cohort perhaps identified by AD genetic risk factors, following this group may offer the prospect of preclinical therapeutic intervention in imminent dementia, a strategy recognized as likely necessary to impact this burgeoning disorder.
淀粉样蛋白低聚物、斑块和磷酸化tau蛋白的连续沉积贯穿犬视网膜的整个生命
目的:大脑淀粉样蛋白负担可在其他认知完整的成年人中发现,通常不会随着年龄的增长而恶化。阿尔茨海默氏症转基因啮齿动物已被广泛用于研究这一现象,但其他动物(如与人类同居的狗,因此可能有一些共同的环境风险)的自发疾病可能有助于并提供在较小的实验室动物中不可能实现的机会。在动物中,与阿尔茨海默病(AD)最相似的自发性疾病影响成熟到老年的狗,被称为犬类认知功能障碍。在阿尔茨海默病的推动下,许多研究表明淀粉样蛋白在犬的中枢神经系统中逐渐积累,包括视网膜。在这里,我们研究了淀粉样蛋白和/或tau沉积是否可以在从一岁到老年的神经正常动物的犬视网膜中发现。假设犬眼淀粉样蛋白和tau蛋白从幼年就存在。在这种情况下,这就提出了一个问题,即类似的积累模式是否也会发生在人类身上,无论是作为衰老、阿尔茨海默病还是其他原因的一部分。方法:本研究使用30只患有各种眼病或其他眼窝疾病的狗的眼组织,其中7/30为1-2岁。组织被细分为三个不同年龄组:幼犬(1-5岁)、中犬(6-10岁)和老年犬(≥11岁)。结果:用抗视网膜Aβ1-40和Aβ1-42低聚物的纳米体以及抗Aβ斑块(Aβp)和过度磷酸化Tau (p-Tau)的抗体对组织切片进行免疫染色后,我们的研究发现,Aβ1-40和Aβ1-42低聚物的积累在所有年龄组的视网膜中都很普遍。相比之下,Aβp在中老年组中检测到,而在年轻组中未检测到。此外,仅在4只老年犬中观察到p-Tau染色,而其他犬则不含p-Tau。有趣的是,Aβo和Aβp在中老年犬群中都有共定位。此外,弥漫性颗粒状p-Tau与细胞内Aβo共定位。最后,我们还观察到Aβo和Aβp在视网膜血管中的共定位,这可能与AD相关的脑淀粉样血管病相似。结论:据我们所知,犬视网膜中淀粉样蛋白和tau蛋白的存在至今未见报道。如果类似的,早期亚临床视网膜沉积发生在可能由AD遗传风险因素确定的人类队列中,那么跟踪这一组可能为即将发生的痴呆提供临床前治疗干预的前景,这一策略被认为可能是影响这种新兴疾病的必要策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信